177Lu-satoreotide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 177Lu-satoreotide, covering 2025-04-13 to 2025-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide [Phase 1, Phase 2]